Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Feb;9(2):296-9.
doi: 10.1002/cmdc.201300404. Epub 2014 Jan 8.

Covalent inhibition of the lymphoid tyrosine phosphatase

Vanessa F Ahmed  1 , Nunzio Bottini, Amy M Barrios
Affiliations

Covalent inhibition of the lymphoid tyrosine phosphatase

Vanessa F Ahmed et al. ChemMedChem. 2014 Feb.

Abstract

Covalent inhibitors of lymphoid tyrosine phosphatase (LYP) were identified from a screen of the NIH Molecular Libraries Small Molecules Repository (MLSMR). Both of the two lead compounds identified have phosphotyrosine-mimetic benzoic acid moieties as well as electrophilic acrylonitrile groups. Inhibition kinetics of both compounds are consistent with covalent modification of the enzyme, with nanomolar KI and reciprocal millisecond kinact values, representing the best efficiency ratios (kinact /KI ) among currently reported covalent LYP inhibitors. Covalent inhibitors can provide longer efficacy and better selectivity than more conventional noncovalent inhibitors, and these lead compounds are an important step toward the development of protein tyrosine phosphatase (PTP)-targeted covalent therapeutic compounds.

Keywords: LYP; PTP; acrylonitriles; electrophiles; irreversible inhibitors; phosphatases.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Structures of two electrophilic compounds with activity as covalent LYP inhibitors.
Figure 2
Figure 2
Time dependent inhibition of LYP by compound 1 (selected progress curves, left panel) and a fit of the kobs data to obtain KI and kinact (right panel).
Figure 2
Figure 2
Time dependent inhibition of LYP by compound 1 (selected progress curves, left panel) and a fit of the kobs data to obtain KI and kinact (right panel).
Figure 3
Figure 3
Time dependent inhibition of LYP by compound 2 (selected progress curves, left panel) and a fit of the kobs data to obtain KI and kinact (right panel).
Figure 3
Figure 3
Time dependent inhibition of LYP by compound 2 (selected progress curves, left panel) and a fit of the kobs data to obtain KI and kinact (right panel).
Scheme 1
Scheme 1
Equation illustrating the irreversible inhibition of an enzyme.
See this image and copyright information in PMC

References

    1. Hunter T. Curr. Opin. Cell Biol. 2009;21:140–146. - PMC - PubMed
    1. Alonso A, Sasin J, Bottini N, Friedberg I, Friedberg I, Osterman A, Godzik A, Hunter T, Dixon J, Mustelin T. Cell. 2004;117:699–711. - PubMed
    1. Bialy L, Waldmann H. Angew. Chem. Int. Ed. 2005;44:2–27. - PubMed
    1. Zhang Z-Y. Curr. Opin. Chem. Biol. 2001;5:416–423. - PubMed
    1. Zhang Z-Y. Annu. Rev. Pharmacol. Toxicol. 2002;42:209–234. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources